When You May Need Submission Support
Submission support may be required when your company is seeking a new procedure code, a DRG change, payer coverage, HTA endorsement or another formal market access decision.
These applications are often complex and time-consuming. They may require coordination with clinical societies, physicians, hospitals, local experts and internal company teams, as well as collection of evidence and data from several sources.
Support is particularly valuable when the submission requires a systematic review of clinical evidence, a health economic analysis, country-specific epidemiology, local costing or a structured response to detailed authority requirements.
What Your Team Will Be Able to Achieve
Our work helps your team:
Reimbursement and HTA Submissions Require More Than a Strong Value Story
A formal submission must do more than describe the benefits of a technology.
It must align with the specific rules of the target process, use the required format, provide appropriate evidence and address the questions that decision-makers will apply.
For reimbursement applications, this may include procedure coding, DRG classification, hospital costs, data from multiple centers, and evidence that the existing payment mechanism is inadequate.
For HTA and coverage submissions, the dossier may require a systematic review of effectiveness and safety, health economic evaluation, budget impact analysis, epidemiology, regulatory information and country-specific data.
Types of Submission Support
Support with applications for the creation of a new procedure code where an existing classification does not adequately describe the technology or procedure.
Support with applications for a new DRG, reclassification into another DRG or another payment adjustment intended to improve hospital reimbursement.
Development of submissions for national or regional HTA, payer coverage or structured introduction processes.
Preparation of the clinical, economic and organizational evidence required to support the application.
Support with authority questions, additional analyses, clarifications and revisions during the review process.
How MTRC Works
We clarify the country, authority, submission pathway, eligibility criteria, timelines and intended market access objective.
We review the available reimbursement analysis, market access strategy, clinical evidence, economic evidence and local data.
We determine what additional evidence, costing, epidemiology, stakeholder input or documentation is required.
We define the core argument, structure, evidence hierarchy, workplan and responsibilities.
We develop the dossier, evidence tables, economic analyses, appendices and supporting documentation in the required format.
We help address reviewer questions, revise the dossier and prepare additional evidence where required.
Geographic Scope
MTRC provides direct support with selected reimbursement and HTA submissions in the Nordic region, the United Kingdom and other selected geographies.
Examples of relevant processes include:
- Procedure code and DRG applications in Denmark
- Procedure code and DRG applications in Finland
- Procedure code, DRG and “New Methods” HTA submissions in Norway
- Procedure code, DRG and “Orderly Introduction” HTA submissions in Sweden
- NICE submissions in the United Kingdom
- Selected HTA submissions in other markets
Discuss Your Reimbursement or HTA Submission
Tell us about your technology, target country, intended process, available evidence and expected timeline.
MTRC will assess the submission pathway and recommend the appropriate scope of support.